Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 111 | 220 | 0 | 10 | 0 |
| Gross Profit | 111 | 220 | N/A | 10 | N/A |
| Operating Expenses | 7,842 | 6,789 | 7,497 | 8,674 | 8,617 |
| Operating Income | -7,731 | -6,569 | -7,497 | -8,664 | -8,617 |
| Interest Expense | 0 | 0 | 0 | 0 | 37 |
| Other Income | 11 | 292 | 9 | -6 | 23 |
| Pre-tax Income | -7,720 | -6,277 | -7,488 | -8,670 | -8,631 |
| Net Income Continuous | -7,720 | -5,641 | -7,488 | -8,670 | -8,631 |
| Net Income | $-7,720 | $-5,641 | $-7,488 | $-8,670 | $-8,631 |
| EPS Basic Total Ops | -0.92 | -0.72 | -0.90 | -0.99 | -1.04 |
| EPS Basic Continuous Ops | -0.92 | -0.72 | -0.90 | -0.99 | -1.04 |
| EPS Diluted Total Ops | -0.92 | -0.72 | -0.90 | -0.99 | -1.04 |
| EPS Diluted Continuous Ops | -0.92 | -0.72 | -0.90 | -0.99 | -1.04 |
| EBITDA(a) | $-7,719 | $-6,543 | $-7,495 | $-8,645 | $-8,447 |